IL92523A0 - Antiviral composition and applications thereof - Google Patents

Antiviral composition and applications thereof

Info

Publication number
IL92523A0
IL92523A0 IL92523A IL9252389A IL92523A0 IL 92523 A0 IL92523 A0 IL 92523A0 IL 92523 A IL92523 A IL 92523A IL 9252389 A IL9252389 A IL 9252389A IL 92523 A0 IL92523 A0 IL 92523A0
Authority
IL
Israel
Prior art keywords
rna
bioparyl
flavopereirine
primers
applications
Prior art date
Application number
IL92523A
Other versions
IL92523A (en
Original Assignee
Fondation Pour L Encouragement
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fondation Pour L Encouragement filed Critical Fondation Pour L Encouragement
Publication of IL92523A0 publication Critical patent/IL92523A0/en
Publication of IL92523A publication Critical patent/IL92523A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A pharmaceutical composition containing: (1) flavopereirine and/or dihydroflavopereirine; (2) one or more compounds selected from the group consisting of naringin, naringenin and/or their esters or salts which are acceptable from a pharmaceutical standpoint; (3) RNA primers or R.L.B. (RNA fragments); (4) bioparyl. Flavopereirine is an alkaloid of the beta-carboline class. R.L.B. are particular fragments of RNA which act as primers for the replication of leucotyte DNA. Bioparyl is obtained from yellow leaves of the Gingko biloba tree by a special process of extraction, hydrolysis and separation. These products in combination are useful for treating patients suffering from viral diseases, especially AIDS.
IL9252389A 1988-12-02 1989-12-01 Antiviral compositions containing flavopereirine and naringenin derivatives, initiator rna and extract from leaves of ginkgo biloba IL92523A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8815845A FR2639830B1 (en) 1988-12-02 1988-12-02 ANTIVIRAL COMPOSITION AND ITS APPLICATIONS

Publications (2)

Publication Number Publication Date
IL92523A0 true IL92523A0 (en) 1990-08-31
IL92523A IL92523A (en) 1994-05-30

Family

ID=9372531

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9252389A IL92523A (en) 1988-12-02 1989-12-01 Antiviral compositions containing flavopereirine and naringenin derivatives, initiator rna and extract from leaves of ginkgo biloba

Country Status (8)

Country Link
EP (1) EP0373986B1 (en)
JP (1) JPH0737393B2 (en)
AT (1) ATE94072T1 (en)
DE (1) DE68909019T2 (en)
DK (1) DK608089A (en)
ES (1) ES2059803T3 (en)
FR (1) FR2639830B1 (en)
IL (1) IL92523A (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02270824A (en) * 1989-04-13 1990-11-05 Snow Brand Milk Prod Co Ltd Reverse transcriptase inhibitor
DE4105570A1 (en) * 1991-02-22 1992-08-27 Helmut Dr Med Scholle USE OF A BACTERIA- AND PROTEIN-FREE FILTRATE
DE4208868A1 (en) * 1992-03-04 1993-09-09 Michaelis Peter Dr Med Use of ginkgolide cpds., esp. ginkgolide B - in treatment of metastatic cancers, to enhance the effect of chemotherapeutic agents
FR2694693B1 (en) * 1992-07-28 1994-10-28 Abrax Bio Labs Sa Pharmaceutical composition based on flavopereirine and its use in a treatment against the HIV virus.
DE4308443C2 (en) * 1993-03-17 1996-09-19 Laves Hans Georg Medicines used to treat retrovirus infections
WO2001003681A2 (en) * 1999-07-08 2001-01-18 Prendergast Patrick T Use of flavones, coumarins and related compounds to treat infections
KR100417172B1 (en) * 2000-08-04 2004-02-05 주식회사 안지오랩 Angiogenesis inhibitor containing ginkgo biloba extract
BRPI0510139A (en) * 2004-05-19 2007-10-02 Natural Source Internat flavopereirine and alstonine combinations in the treatment and prevention of prostate cancer
CN107501224B (en) * 2017-09-12 2021-01-19 临沂金卓生物科技有限公司 Method for producing flavonoid aglycone by catalyzing and hydrolyzing ginkgo flavone glycoside with zeolite molecular sieve
US11083714B2 (en) 2018-03-31 2021-08-10 Molecular International Research, Inc. Selective anti-cancer agent effective for prevention and treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2450607A2 (en) * 1978-03-13 1980-10-03 Beljanski Mirko Antiviral, anticancer, antitumour flavopereirine compsn. - activity tests for semperverine, serpentine and alstonine are also given
ATE15971T1 (en) * 1981-03-11 1985-10-15 Mirko Beljanski SERPENTIN, ALSTONIN AND SEMPERVIRIN, MEDICATIONS THAT SPECIFICALLY INHIBIT TUMOR AND CANCER CELLS.

Also Published As

Publication number Publication date
ES2059803T3 (en) 1994-11-16
DE68909019D1 (en) 1993-10-14
EP0373986A1 (en) 1990-06-20
JPH02184632A (en) 1990-07-19
DK608089D0 (en) 1989-12-01
JPH0737393B2 (en) 1995-04-26
IL92523A (en) 1994-05-30
DE68909019T2 (en) 1994-03-17
FR2639830B1 (en) 1991-03-22
EP0373986B1 (en) 1993-09-08
DK608089A (en) 1990-06-03
FR2639830A1 (en) 1990-06-08
ATE94072T1 (en) 1993-09-15

Similar Documents

Publication Publication Date Title
HU9401445D0 (en) Nor-bile-acid derivatives, process for producing them and pharmaceutical compositions containing them
EP0339237A3 (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them
DZ1227A1 (en) Benzopyran derivatives process for their preparation and drugs containing said derivatives.
PT88930A (en) METHOD FOR THE PREPARATION OF NEW ANALYSES OF NUCLEOSIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IL92523A0 (en) Antiviral composition and applications thereof
CA2067381A1 (en) Treatment of hiv infections and compounds useful therein
EP0403048A3 (en) Medicated compositions containing sucralfate and processes for their production
DE68929388D1 (en) Anticoagulant compound isolated from urine
ATE74768T1 (en) SOLID PHARMACEUTICAL PREPARATION AND PROCESS FOR MAKING THE SAME.
AU2894389A (en) Novel preparation and method of use thereof
ATE77239T1 (en) PREPARATION FOR STIMULATION OF CHONDROCYTES AND OSTEOBLAST (OSSEIN HYDROXYAPATITE COMPOUND), METHOD OF MANUFACTURE AND PHARMACEUTICAL PRODUCTS CONTAINING THEM.
EP0197488A3 (en) 1,4-Dihydropyiridine derivative, a process for preparing the same, a pharmaceutical composition as well as the use thereof
DE3887068D1 (en) 2,2-Dimethylchromene derivatives, process for their preparation and pharmaceutical compositions containing them.
WO1990013281A3 (en) Method of suppressing hiv infection
JPS57203017A (en) Purifying method of immunoglobulin
EP0319962A3 (en) Piperidinyl methanol derivatives for the treatment of anxiety
ATE102623T1 (en) THEOPHYLLINEMETHYLDITHIOLANE AND THEOPHYLLINEMETHYLDITHIANYL DERIVATIVES, A PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
AU2126288A (en) Thiosulphinic acid derivatives, their use in the treatment of inflammatory diseases, and drugs containing them
FR2603587B1 (en) 2,3,4,5,6,7-HEXAHYDRO-2,7-METHANO-1,5-BENZOXAZONINE (OR -1,4-BENZOXAZONINE) DERIVATIVES, PROCESS FOR THEIR PREPARATION, MEDICAMENTS CONTAINING THEM AND INTERMEDIATE COMPOUNDS
FR2595697B1 (en) BENZYL-PYRIMIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM
DE3769358D1 (en) 1-ACYL-2,3-DIHYDRO-4 (1H) -QUINOLINONE-4-OXIME DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATE PRODUCTS.
PT90169A (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS CONTAINING TIMOPENTIN FOR THE TREATMENT OF PATIENTS SUFFERING FROM VIREMIAS PROVOCADO BY HIV
WO1989000571A3 (en) Bicyclic compounds, their use as pharmaceuticals, their preparation, and intermediates useful in their preparation
FR2617481B1 (en) NOVEL TETRAHYDROPYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PREPARATION INTERMEDIATES, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
SE8802480L (en) PROCEDURES FOR PREPARING NUCLEIC ACID DERIVATIVES AND PROCEDURES FOR PREPARING MEDICAL COMPOSITION CONTAINING THEM

Legal Events

Date Code Title Description
KB Patent renewed
RH Patent void
NE Application for restoration - patent lapsed through non-payment of renewal fees (section 60, patents law, 5727-1967)
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees